RecruitingNCT06280664
Efficacy Of Hiatal Closure For GERD
Sponsor
University of Chicago
Enrollment
40 participants
Start Date
Oct 2, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.
Eligibility
Min Age: 18 YearsMax Age: 50 Years
Inclusion Criteria6
- Age 18 - 50 years
- Able to provide informed consent
- BMI <30
- Hiatal defect <4cm on esophagram
- pH testing requirement: pH <4 for >5.5%
- Surgical candidate for hiatal closure only
Exclusion Criteria1
- Vulnerable subjects (children, prisoners, pregnant women) will be excluded.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06280664
Related Trials
Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
NCT044940481 location
Validation of the C-mo System - Cough Monitoring
NCT059896988 locations
Clinical Utility of WATS3D: A 5-Year Prospective Study
NCT043126331 location
Prevalence of Symptomatic Gastroesophageal Reflux Disease in Czech Children (Czech GERDKids)
NCT074829691 location
Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study)
NCT055704481 location